Trials / Conditions / Limited-stage Small Cell Lung Cancer (LS-SCLC)

Limited-stage Small Cell Lung Cancer (LS-SCLC)

8 registered clinical trials studyying Limited-stage Small Cell Lung Cancer (LS-SCLC) — 6 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	A Prospective, Multicenter Exploratory Clinical Study on Consolidation Therapy With Tislelizumab Combined With NCT07485920	The Affiliated Hospital of Qingdao University	Phase 4
Active Not Recruiting	A Study of QL1706 Combined With Chemotherapy Induction on Sequential Immunotherapy Consolidation in Patients W NCT07091305	Shanghai Chest Hospital	Phase 2
Not Yet Recruiting	Hypofractionated Radiotherapy Followed by Chemo-immunotherapy Induction Therapy NCT06914050	Tianjin Medical University Cancer Institute and Hospital	Phase 2
Recruiting	Prediction of Response to PD-L1 Inhibitor After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer Usin NCT06869239	Peking University Cancer Hospital & Institute	—
Recruiting	Concurrent Chemoradiotherapy Combined With Toripalimab and Surufatinib in the Treatment of Limited-Stage Small NCT06719700	Sun Yat-sen University	Phase 2
Enrolling By Invitation	Adjuvant Adebrelimab Plus Apatinib After Chemoradiation in Limited-Stage Small Cell Lung Cancer NCT06773156	Second Affiliated Hospital of Nanchang University	Phase 2
Recruiting	Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients Wi NCT06095583	Shanghai Junshi Bioscience Co., Ltd.	Phase 3
Unknown	A Trial of SHR-1316 Maintenance Therapy for Limited Stage Small Cell Lung Cancer NCT04647357	Union Hospital, Tongji Medical College, Huazhong University of Science and Technology	Phase 2